These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2981080)

  • 1. Hepatocellular carcinoma: an unusual course with hyperthyroidism and inappropriate thyroid-stimulating hormone production.
    Helzberg JH; McPhee MS; Zarling EJ; Lukert BP
    Gastroenterology; 1985 Jan; 88(1 Pt 1):181-4. PubMed ID: 2981080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients.
    Wynne AG; Gharib H; Scheithauer BW; Davis DH; Freeman SL; Horvath E
    Am J Med; 1992 Jan; 92(1):15-24. PubMed ID: 1346235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of "inappropriate secretion of TSH".
    Gershengorn MC; Weintraub BD
    J Clin Invest; 1975 Sep; 56(3):633-42. PubMed ID: 1159077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid function in molar pregnancy.
    Nagataki S; Mizuno M; Sakamoto S; Irie M; Shizume K
    J Clin Endocrinol Metab; 1977 Feb; 44(2):254-63. PubMed ID: 402378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.
    Papi G; Pearce EN; Braverman LE; Betterle C; Roti E
    Am J Med; 2005 Apr; 118(4):349-61. PubMed ID: 15808130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus.
    Thorpe-Beeston JG; Nicolaides KH; Felton CV; Butler J; McGregor AM
    N Engl J Med; 1991 Feb; 324(8):532-6. PubMed ID: 1899469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
    Spitz IM; Sheinfeld M; Glasser B; Hirsch HJ
    Postgrad Med J; 1984 May; 60(703):328-35. PubMed ID: 6429655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroidism from thyroid metastasis of pancreatic adenocarcinoma.
    Eriksson M; Ajmani SK; Mallette LE
    JAMA; 1977 Sep; 238(12):1276-8. PubMed ID: 578180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of routine serum-triiodothyronine estimation in diagnosis of thyrotoxicosis.
    Shalet SM; Beardwell CG; Lamb AM; Gowland E
    Lancet; 1975 Nov; 2(7943):1008-10. PubMed ID: 53496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin.
    Mooney CT; Thoday KL; Doxey DL
    Am J Vet Res; 1996 Jul; 57(7):987-91. PubMed ID: 8807008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behaviour of thyroid hormones in an infant with untreated neonatal thyrotoxicosis.
    Wilkin TJ; Kenyon E; Isles TE
    Clin Endocrinol (Oxf); 1977 Sep; 7(3):227-31. PubMed ID: 908154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroxine uptake by human hepatoma cells from serum of patients submitted to long-term thyroxine suppressive therapy.
    Bartalena L; Martino E; Falcone M; Pacchiarotti A; Pinchera A
    J Endocrinol Invest; 1988 Oct; 11(9):629-35. PubMed ID: 2851621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic thyroid cancer with transient thyrotoxicosis: case report and literature review.
    Alagöl F; Tanakol R; Boztepe H; Kapran Y; Terzioglu T; Dizdaroglu F
    Thyroid; 1999 Oct; 9(10):1029-32. PubMed ID: 10560959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diminution of thyroid stimulating hormone level but normal levels of thyroid hormones. Demonstration of occult hyperthyroidism].
    Schlienger JL; Klerlein M; Sapin R; Demangeat JL; Imler M
    Presse Med; 1989 Apr; 18(14):707-10. PubMed ID: 2471184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thyroxine, triiodothyronine, T3 uptake and thyroid stimulating hormone concentrations in infancy, childhood, adolescence and pediatric thyroid disorders.
    Chen SH; Hwang LY; Wu HH; Huang SZ; Chen CH; Lee TC
    Taiwan Yi Xue Hui Za Zhi; 1980 Apr; 79(4):379-86. PubMed ID: 6931185
    [No Abstract]   [Full Text] [Related]  

  • 17. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
    Rösler A; Litvin Y; Hage C; Gross J; Cerasi E
    J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical evaluation of patients with subclinical hyperthyroidism and free triiodothyronine (free T3) toxicosis.
    Figge J; Leinung M; Goodman AD; Izquierdo R; Mydosh T; Gates S; Line B; Lee DW
    Am J Med; 1994 Mar; 96(3):229-34. PubMed ID: 8154510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ACTH-stimulated glucocorticoid hypersecretion on the serum concentrations of thyroxine-binding globulin, thyroxine, triiodothyronine, reverse triiodothyronine and on the TSH-response to TRH.
    Bános C; Takó J; Salamon F; Györgyi S; Czikkely R
    Acta Med Acad Sci Hung; 1979; 36(4):381-94. PubMed ID: 233400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression.
    Lewis GF; Alessi CA; Imperial JG; Refetoff S
    J Clin Endocrinol Metab; 1991 Oct; 73(4):843-9. PubMed ID: 1653784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.